Results 101 to 110 of about 2,336 (164)

Development and evaluation of a dual target glycoconjugate vaccine against Shigella sonnei

Hall CL, Flood TL, Clare S, Harcourt K, Kay E, Baker S, Wren BW.   +6 more
europepmc   +1 more source

Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1. [PDF]

ACS Cent Sci, 2018
Schumann B, Reppe K, Kaplonek P, Wahlbrink A, Anish C, Witzenrath M, Pereira CL, Seeberger PH.   +7 more
europepmc   +1 more source

Correction to “Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines” [PDF]

Accounts of Chemical Research, 2017
openaire   +2 more sources

A Semi-Synthetic Glycoconjugate Vaccine Candidate for Carbapenem-Resistant Klebsiella pneumoniae. [PDF]

Angew Chem Int Ed Engl, 2017
Seeberger PH, Pereira CL, Khan N, Xiao G, Diago-Navarro E, Reppe K, Opitz B, Fries BC, Witzenrath M.   +8 more
europepmc   +1 more source

The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi. [PDF]

PLoS One, 2017
Arcuri M, Di Benedetto R, Cunningham AF, Saul A, MacLennan CA, Micoli F.   +5 more
europepmc   +1 more source

Synthetic PS-III Glycoconjugate Vaccines Based on Solid-Phase Assembled Well-Defined Oligosaccharides Confers Protection against <i>Clostridium difficile</i>. [PDF]

ACS Cent Sci
Chen Y, Liu X, Zhang T, Wang Z, Li Y, Zeng J, Li H, Zong C, Liu Q.   +8 more
europepmc   +1 more source

Multicomponent polysaccharide-protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates. [PDF]

Chem Sci, 2018
Méndez Y, Chang J, Humpierre AR, Zanuy A, Garrido R, Vasco AV, Pedroso J, Santana D, Rodríguez LM, García-Rivera D, Valdés Y, Vérez-Bencomo V, Rivera DG.   +12 more
europepmc   +1 more source

Chemical Synthesis and Immunological Evaluation of Escherichia coli O29, Shigella dysenteriae Serotype 11, and Proteus vulgaris O12 O-Antigen Oligosaccharides. [PDF]

Angew Chem Int Ed Engl
Li X, Wang X, Deng L, Ji X, Tu Y, Liu C, Wang Z, Wang L, Ye X, Yang Y, Zhang Q.   +10 more
europepmc   +1 more source

The status quo and evolution of glycoconjugates for cancer immunotherapy. [PDF]

Glycoconj J
Singh Y, Kamra M.
europepmc   +1 more source

Unlocking the Potency of Keyhole Limpet Hemocyanin: Structural Insights, Immunological Mechanisms, and Therapeutic Frontiers. [PDF]

Int J Mol Sci
Cermakova P, Cehlar O, Piestansky J.
europepmc   +1 more source